Are You Looking for a Top Momentum Pick? Why Novo Nordisk (NVO) is a Great ChoiceZacks Investment Research • 04/14/23
Novo Nordisk Surges To Another Record As Obesity Drugs Drive Higher OutlookInvestors Business Daily • 04/13/23
Vancouver, B.C., tissue ‘bioprinting' company inks $75M deal with Novo Nordisk for diabetes, obesityGeekWire • 04/12/23
Red-Hot Obesity-Drug Maker Novo Nordisk Soars To Record On A $725 Million DealInvestors Business Daily • 04/12/23
Which Healthcare Company Will Be the First to Get to a $1 Trillion Market Cap?The Motley Fool • 04/12/23
Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesityGlobeNewsWire • 04/12/23
Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the MarketThe Motley Fool • 04/06/23
The Government Move That Could Drive Obesity Drugs — And Lilly, Novo SharesInvestors Business Daily • 03/29/23
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh WinInvestors Business Daily • 03/24/23